The toxic bite of a Gila monster can kill a human, but a specific ingredient in the cocktail of the lizard's venom is the reason we have glucagon-like peptide (GLP-1) agonists like Ozempic and Wegovy.
Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...